KRP 101
Alternative Names: KRP-101Latest Information Update: 08 Feb 2010
At a glance
- Originator Kyorin Pharmaceutical
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus; Hyperlipidaemia; Metabolic disorders
Most Recent Events
- 08 Nov 2004 Phase-II clinical trials in Diabetes mellitus in United Kingdom (PO)
- 08 Nov 2004 Phase-II clinical trials in Hyperlipidaemia in United Kingdom (unspecified route)
- 30 Sep 2003 Phase-I clinical trials in Hyperlipidaemia in United Kingdom (unspecified route)